LSD was initially explored for psychiatric use due to its structural similarity to the neurotransmitter serotonin and its safety profile.27 In the 1950s and 1960s, it was used in psychiatry to enhance psychotherapy, known as psychedelic therapy.
Albert Kurland and his colleagues published research on LSD’s therapeutic potential to treat schizophrenia. By the 1960s however, controversies surrounding “hippie” counterculture began to deplete institutional support for continued studies. In a recent study, Gonzalez‐Maeso et al. 156 compared 2‐HT2A agonists with and without hallucinogenic activity in mice. It was found that these types of agonists differ in regard to the G‐protein activiation induced, especially those of the pertussis toxin‐sensitive heterotrimeric Gi/o and Ga/11 proteins and their coactivation. This may imply that the hallucinogenic effects are mainly mediated by cortico‐cortical neural circuits rather than by thalamo‐cortical circuits as proposed earlier by some scientists 133.
Interactions of LSD with Other Substances
Serotonin (5‐hydroxytryptamine; 5‐HT) is produced by a small number of neurons (1000s) that each innervate as many as 500,000 other neurons. For the most part, these neurons originate in the raphe nuclei (RN) of the midbrain. One major target of these is the locus coeruleus (LC), which controls the release of norepinephrine, which regulates the sympathetic nervous system. The LC also has neurons that extend into the cerebellum, thalamus, hypothalamus, cerebral cortex, and hippocampus.
Notable individuals
LSD isn’t considered an addictive substance, according to the National Institute on Drug Abuse, but you can develop a tolerance to it and other hallucinogens if you take it often. An LSD hangover can leave you feeling “off” for a few hours or days. For most people, the entire experience from trip to comedown lasts around 24 hours.
- The average time for determination of LSD in blood specimens is estimated to be 6–12 h and 2–4 days in urine specimens 109, 111, 115.
- A strong correlation was described between psychoactive doses of these hallucinogens and their respective potency at the 5‐HT2 receptor 150, 151.
- Actually there is new interest in LSD as an experimental tool for elucidating neural mechanisms of (states of) consciousness and there are recently discovered treatment options with LSD in cluster headache and with the terminally ill.
- From the mid 1960s, it became an illegal drug of abuse with widespread use that continues today.
Jarvik et al. 40 found that 100 μg LSD significantly impaired performance on arithmetic while 50 μg had no such effect. Memory was also affected by LSD as was lsd what to know illustrated with the Wechsler Bellevue Scale 41. Impairment of visual memory was shown in the Bender–Gestalt test 34. Thinking processes are more resistant but can be also affected when higher doses of LSD are given 42, 43. Under the influence of LSD, subjects will overestimate time intervals 44.
Regional Distribution in Brain Tissue
In turn, one could predict that reabsorption of 5‐HT2A receptors will not be complete after single predosing with an SSRI or MAOIs; in such circumstances, the risk for serotonin syndrome may be heightened. Lithium and some tricyclic antidepressants have also been reported to increase the effects of LSD 180. It has to be mentioned that LSD in combination with lithium drastically increases LSD reactions and can lead to temporary comatose states as suggested by anecdotal medical reports 182.
The digestive tract contains 70–80% of the radioactivity 3–12 h after ingestion 92. The threshold dose for measurable sympathomimetic effects in humans is 0.5–1.0 μg/kg LSD p.o. A moderate dose of LSD for humans is estimated as 75–150 μg LSD p.o. Dosing of animals (rats and cats) with very high doses of LSD (up to 100 μg/kg i.v.) leads to mild autonomic changes of mydriasis, tachycardia, tachypnea, hyperthermia, hypertonia, and hyperglycemia 65. These changes may be the result of an excitatory syndrome caused by central stimulation of the sympathetic system.
How long do the effects of LSD last, and how long does it stay in the body?
- Beyond objectively measurable somatic changes, there are other somatic symptoms experienced by some subjects (cf. Table 1).
- Serotonin (5‐hydroxytryptamine; 5‐HT) is produced by a small number of neurons (1000s) that each innervate as many as 500,000 other neurons.
- Patient confidentiality laws prevent your doctor from sharing this information.
- It has been suggested that neurons in this brain region may inhibit sensation, thus protecting the brain from sensory overload.
- The fact that the LC and the RN innervate virtually every part of the brain shows that serotonin can activate large portions of the brain from a relatively small area of origination 146.
Other researchers describe a progressive desynchronization due to a quantitative decrement of the slow component after LSD 124, 125. Goldstein et al. 126 reported a decrease of EEG variability of 33% after LSD (0.3–1.0 μg/kg p.o.). Goldstein and Stoltzfus 127 analyzed human EEG amplitude levels in right and left occipital areas and found that in most subjects the normal pattern of lateralization was reversed by LSD.
Other substances
A moderate dose of LSD (100–200 μg p.o.) within a few hours after ingestion results in plasma and urine concentrations at the sub‐ng/mL level 111. LSD content of body fluids may be detected by RIA and enzyme immunoassay. Laboratory tests have shown that RIA results are accurate down to at least 0.5 ng/mL 112. A new indirect enzyme‐linked immunosorbent assay (ELISA) was used to detect as little as 1 pg of total drug in 25 μL blood 113.
The concentrations of LSD in urine samples were followed over time at various temperatures, in different types of storage containers, at various exposures to different wavelengths of light, and at varying pH values. These studies demonstrated no significant loss in LSD concentration at 25 °C for up to four weeks. After four weeks of incubation, a 30% loss in LSD concentration at 37 °C and up to a 40% at 45 °C were observed. Urine fortified with LSD and stored in amber glass or nontransparent polyethylene containers showed no change in concentration under any light conditions.
Nichols and Sanders‐Bush 157 first described an LSD‐mediated increase in gene expression, which Nichols et al. 158 found to be due to activation of 5‐HT2A receptors. Forrer and Goldner 68 and Hertle et al. 120 described a dose‐dependent hyperreflexia and a mild ataxia as the major neurological effects of LSD. The half‐life in mice (2 mg/kg i.p.) is 7 min, 130 min in cats (0.2 mg/kg i.v.), and 100 min in monkeys (M. mulatta) (0.2 mg/kg i.v.) 97. The presence of considerable amounts of the drug in the brain and cerebrospinal fluid (CSF) of rats and cats indicates that LSD may easily pass the blood–brain barrier 97.
Since LSD is not an approved drug, its therapeutic applications are regarded as experimental. In the 1960s LSD was proposed for use in the treatment of neuroses, especially for patients who were recalcitrant to more conventional psychotherapeutic procedures. LSD also was tried as a treatment for alcoholism and to reduce the suffering of terminally ill cancer patients. It was studied as an adjunct in the treatment of narcotic addiction, of children with autism, and of the so-called psychopathic personality. None of those uses were successful by the early 1990s, and most researchers concluded that there was no clinical value in the use of LSD.
It should be noted, however, that these generally take place in uncontrolled conditions. Conversely, it has been shown that under controlled and supportive conditions, the LSD experience may have lasting positive effects on attitude and personality 32. Lysergic acid diethylamide (LSD) is a semisynthetic product of lysergic acid, a natural substance from the parasitic rye fungus Claviceps purpurea. Albert Hofmann, a natural products chemist at the Sandoz AG Pharmaceutical Company (Basel, Switzerland) synthesized it in 1938 while searching for pharmacologically active derivatives of lysergic acid. He accidentally discovered its dramatic psychological effects in 1943. Though he synthesized many lysergic acid derivatives, none had LSD’s unique spectrum of psychological effects.
How do people make acid?
Lower concentrations were found in the lungs, liver, brain, digestive tract, spleen, and muscle, with the lowest concentrations found in fat tissue 93, 97. In mice, 14C‐LSD (50 μg i.v.) disappeared in a few minutes from blood and was found within 10 min in nearly all organs 90. In the duodenum, the activity reached a maximum (with 50% of radioactivity) at the 2 h mark. 14C‐LSD is then transported in the chyme through the digestive tract and reaches a maximum in the colon after approximately 3 h (see Figure 3) 91.
The effects of LSD on blood pressure are probably complex, because of its in situ action on blood vessels, cardiac and other muscular systems, lungs, and respiration, as well as its effects on the central nervous system and carotid sinuses. The most sensitive species is the rabbit, with an LD50 of 0.3 mg/kg i.v. The LD50 for rats (16.5 mg/kg i.v.) is much higher 52, 53, though mice tolerate doses of 46–60 mg/kg i.v. Monkeys (Macaca mulatta) have been injected with doses as high as 1 mg/kg i.v. Sheridan holds an MBChB (MD) from the University of Pretoria and an MPhil in Applied Ethics (Bioethics) from Stellenbosch University, where he focused on compassionate clinical responses to substance use disorders (SUD). LSD’s effects last 8-12 hours, and its traces may remain in the body for up to 2 days.